Cephapirin Sodium

Verify with FDA CVM →

368 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
368
Total Reports
5
Deaths Reported
140.0%
Death Rate

Active Ingredients

Cephapirin Sodium

Administration Routes

IntramammaryUnknownOralTopicalIntramuscularIntralesional

Species Affected

Cattle 286
Unknown 74
Goat 3
Horse 2
Human 1
Dog 1
Sheep 1

Most Affected Breeds

Holstein-Friesian also known as Holstein 199
Unknown 78
Cattle (other) 48
Cattle (unknown) 15
Jersey 13
Crossbred Bovine/Cattle 6
Goat (unknown) 2
Tennessee Walking Horse 1
Goat (other) 1
Ayrshire 1

Most Reported Reactions

Residues in milk 179
Drug dose administration interval too long 74
INEFFECTIVE, ANTIBIOTIC 51
Lack of efficacy (bacteria) - NOS 43
Tubes, Damaged 16
Product syringe issue 13
Tubes, Abnormal 12
Containers, Damaged 12
Product Defect, General 11
Product problem 9
Drug administration duration too long 9
Uncoded sign 8

Outcome Breakdown

Recovered/Normal
139 (52.5%)
Outcome Unknown
113 (42.6%)
Ongoing
6 (2.3%)
Died
3 (1.1%)
Recovered with Sequela
2 (0.8%)
Euthanized
2 (0.8%)

Data Summary

Metric Value
Total adverse event reports 368
Reports involving death 5
Case-fatality rate (reported events) 140.0%
Distinct species in reports 7
Distinct breeds in reports 14
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cephapirin Sodium Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 368 adverse event reports referencing Cephapirin Sodium, including 5 reports in which the animal died — a 140.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cephapirin Sodium. Reported administration routes include Intramammary, Unknown, Oral, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cephapirin Sodium reports are Cattle (286 reports), Unknown (74 reports), Goat (3 reports), with Cattle accounting for the largest share. Within those species, Holstein-Friesian also known as Holstein (199), Unknown (78), Cattle (other) (48) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cephapirin Sodium are Residues in milk (179), Drug dose administration interval too long (74), INEFFECTIVE, ANTIBIOTIC (51), Lack of efficacy (bacteria) - NOS (43). Of the 265 reports with a coded outcome, Recovered/Normal is the leading category at 52.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cephapirin Sodium.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial